PDA

View Full Version : ARIMIDEX Offers Women Greater Protection Against HR+ Early Breast Cancer Returning In


News
03-13-2009, 11:10 AM
"Anastrozole is the only aromatase inhibitor (AI) which has now been shown to prevent recurrences in women with hormone receptor positive early breast cancer both during the initial high-risk two years after surgery, and also well beyond the completion of treatment.

More... (http://www.medicalnewstoday.com/articles/142178.php)